Linked Life Data

18376461

Source:http://linkedlifedata.com/resource/pubmed/id/18376461

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2008-3-28
pubmed:abstractText
Image-guided tumor ablation has a major role in the therapeutic management of hepatocellular carcinoma and the assessment of the efficacy of percutaneous ablation is crucial for the management of cirrhotic patients. Contrast-enhanced ultrasonography (CEUS) is extremely sensitive in detecting the intratumoral microvasculature in real time, with the same sensitivity in the detection of residual HCC as CT. CEUS has some advantages. It can be used before and during the ablative procedure as a guide for percutaneous needle placement. Moreover, CEUS can be performed almost immediately after ablation to determine whether the tumor has been completely ablated or needs additional treatment that can be performed in the same session, improving the cost-effectiveness of the treatment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0938-7994
pubmed:author
pubmed:issnType
Print
pubmed:volume
17 Suppl 6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
F80-8
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Early-stage hepatocellular carcinoma: the high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment.
pubmed:affiliation
Imaging Diagnosis Center, Hospital Clinic, Barcelona, Spain. cnicolau@clinic.ub.es
pubmed:publicationType
Journal Article, Review